Literature DB >> 15992087

Animal models of psoriasis.

B J Nickoloff1.   

Abstract

Psoriasis is a common and chronic skin disorder under active investigation around the world. Despite this, determination of its genetic basis, role of the immune system in the disease pathophysiology and development of effective therapy, have been hampered severely by the absence of any spontaneous psoriatic skin disease in animals. Furthermore, until recently, validated animal models designed to create psoriasis were unavailable to investigative skin biologists and clinical scientists. However, there is at least one animal model which has been established and validated; it uses human skin engrafted on to severe combined immunodeficient (SCID) mice. In addition, there are several other rodent models which do not involve transplantation technology that share some (but not all) features in common with psoriasis. This review will summarise these available animal models and critique their relevance with respect to illuminating the immunogenetic basis of psoriasis and their value in screening novel treatments in a preclinical setting.

Entities:  

Year:  1999        PMID: 15992087     DOI: 10.1517/13543784.8.4.393

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  5 in total

1.  Skin Diseases in Laboratory Mice: Approaches to Drug Target Identification and Efficacy Screening.

Authors:  John P Sundberg; Kathleen A Silva; Lloyd E King; C Herbert Pratt
Journal:  Methods Mol Biol       Date:  2016

Review 2.  Mouse Models of Alopecia Areata: C3H/HeJ Mice Versus the Humanized AA Mouse Model.

Authors:  Amos Gilhar; Rimma Laufer Britva; Aviad Keren; Ralf Paus
Journal:  J Investig Dermatol Symp Proc       Date:  2020-11

3.  Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis.

Authors:  Kathy Lee; Gautam Adhikary; Sivaprakasam Balasubramanian; Ramamurthy Gopalakrishnan; Thomas McCormick; Goberdhan P Dimri; Richard L Eckert; Ellen A Rorke
Journal:  J Invest Dermatol       Date:  2007-07-12       Impact factor: 8.551

4.  AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation.

Authors:  E A Rorke; G Adhikary; R Jans; J F Crish; R L Eckert
Journal:  Oncogene       Date:  2010-09-06       Impact factor: 9.867

Review 5.  Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases.

Authors:  Györgyi Műzes; Ferenc Sipos
Journal:  Cells       Date:  2022-07-26       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.